Evidence map›Paper›PMID 17450357›Full record

ReviewEuropean journal of nuclear medicine and molecular imaging2007

Neuronal imaging using SPECT.

Shohei Yamashina, Jun-ichi Yamazaki

Abstract readReview
PubMed Publisher
In one paragraph

Review in European journal of nuclear medicine and molecular imaging, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Review
  3. Article
  4. ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2016
    Article
  5. Article
  6. Article
  7. Cardiac autonomic imaging with SPECT tracers.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2013
    Review
  8. Molecular imaging in heart failure patients.Clinical and translational imaging · 2013
    Review
  9. Takotsubo syndrome in a patient after renal transplantation.Medical science monitor : international medical journal of experimental and clinical research · 2012
    Article
  10. Article
  11. Article
  12. Nuclear imaging in cardiac amyloidosis.European journal of nuclear medicine and molecular imaging · 2009
    Review
  13. Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
    Article
  14. Effect of spinal cord stimulation on cardiac adrenergic nerve function in patients with cardiac syndrome X.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shohei YamashinaDepartment of Cardiovasular Medicine, Toho University Omori Medical Center, 6-11-1 Omori-nishi, Ota-ku, Tokyo 143-8541, Japan. shohei@uhchan.com
Jun-ichi Yamazaki

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(123)I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy is one of only a few methods available for objective evaluation of cardiac sympathetic function at the clinical level. Disorders of cardiac sympathetic function play an important role in various heart diseases, and MIBG provides an abundance of useful information for the evaluation of severity, prognosis and therapeutic effects; this is particularly useful in cases of heart failure, ischaemic heart disease and arrhythmic disease. On the other hand, the quantitative indices for MIBG differ between institutions, and evidence has not been sufficiently well established for MIBG scintigraphy when compared with myocardial perfusion imaging in ischaemic heart diseases. In consideration of these difficulties, this review provides fundamental information regarding MIBG, its usefulness for various diseases and future difficulties.

Indexed as

3-IodobenzylguanidineAutonomic Nervous System DiseasesHeartHeart DiseasesHumansNeuronsRadiopharmaceuticalsTomography, Emission-Computed, Single-Photon3-IodobenzylguanidineRadiopharmaceuticals

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.